Elanor secures 2 key medical assets
Johnson Winter & Slattery (JWS) has advised Elanor Investors Group on its acquisition of two health and medical sector assets.
Firm: Johnson Winter & Slattery (Elanor Investors Group)
Deal: Johnson Winter & Slattery (JWS) has advised Elanor Investors Group on its $123 million acquisition of two health and medical sector assets in Queensland from healthcare real estate investment trust NorthWest.
Elanor Investors Group is an ASX-listed Australian real estate investment and funds management business with over $1.7 billion of assets across Australia and New Zealand.
Value: $123 million.
Key players: The JWS team advising on the transaction was led by real estate partner Peter Trevaskis, who worked alongside senior associate Stephanie Chun, and associates Lucy Wang and Anna Shilova.
Partner Andy Milidoni advised on the tax aspects of this transaction.
Deal Significance: The acquisitions seed Elanor Investors Group’s unlisted healthcare fund, which now comprises two multitenanted medical office and day surgeries at 55 Little Edward Street, Spring Hill, Brisbane and Pacific Private, 123 Nerang Street, Southport, Gold Coast.
The group’s co-head of real estate David Burgess said the acquisition of the two seed assets is a positive starting point.
“The seed assets represent high investment quality commercial healthcare properties, underpinned by strong anchor tenants,” Mr Burgess said.
Mr Trevaskis said the firm was delighted to have supported Elanor on its strategic and timely investment.
“Elanor Investment Group is focused on securing assets that provide strong income and high-quality capital growth potential for its funds management capital partners and Elanor security holders,” Mr Trevaskis said.
“With the current economic climate, investing in medical facilities is a strong strategy for the group, demonstrating its ability to show foresight and adapt quickly to market trends.”